Aker BioMarine ASA Company Description
Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide.
It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business.
The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LYSOVETA brand; and marine-origin DHA omega-3 from microalgae under the Revervia brand name, as well as advanced phospholipid technology under PL+ name.
The Consumer Health Products segment sells processed and packaged krill, fish, and plants derived raw materials to retailers in the United States.
The Emerging Business segment offers krill oil under Kori brand name. The company provides protein solutions under the Understory brand; biostimulants under KRBNX brand; and a therapeutic candidate based on omega-3 to manage and treat cardiometabolic diseases under CaPre brand name, as well as delivers circular products utilizing recycled industrial and marine plastic waste under AION name.
Aker BioMarine ASA was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.
Country | Norway |
Founded | 2006 |
Industry | Packaged Foods |
Sector | Consumer Staples |
Employees | 249 |
CEO | Matts Johansen |
Contact Details
Address: Oksenøyveien 10 Lysaker, 1327 Norway | |
Phone | 47 24 13 00 00 |
Website | akerbiomarine.com |
Stock Details
Ticker Symbol | AKBM |
Exchange | Oslo Børs |
Fiscal Year | January - December |
Reporting Currency | USD |
ISIN Number | NO0010886625 |
SIC Code | 0900 |
Key Executives
Name | Position |
---|---|
Seth French | Chief Executive Officer of Lang Pharma Nutrition Inc |
Simon Seward | Chief Executive Officer of Human Health Ingredients |
Trond Atle Smedsrud | Chief Executive Officer of Emerging Business |
Matts Johansen | Chief Executive Officer |
Katrine Mourud Klaveness | Chief Financial Officer |
Hege Spaun | Chief Officer People and Communication |
Christopher Robin Vinter | Vice President of IR and Corporate Finance |
Tone Lorentzen | Chief Operating Officer of Human Health Ingredients |
Lise Wiger | Financial Controller |
Anniken Færgestad | Vice President of Finance |